Literature DB >> 10924528

G(olf)alpha mediates dopamine D1 receptor signaling.

X Zhuang1, L Belluscio, R Hen.   

Abstract

It is generally assumed that the coupling of dopamine D1 receptors to adenylyl cyclase is mediated by the stimulatory GTP-binding protein G(s). However, the striatum contains little G(s)alpha subunit, whereas it expresses high levels of G(olf)alpha, a close relative of G(s)alpha that is also expressed in olfactory receptor neurons. We used G(olf)alpha knockout mice to examine the functional coupling of D1 receptors. We found that these mice showed no hyperlocomotor response to either the D1 agonist SKF-81297 or the psychostimulant cocaine. Moreover, G(olf)alpha knockout mice did not display cocaine-induced c-fos expression in the striatum. Finally, in the absence of G(olf)alpha, striatal D1 receptors have a decreased affinity for dopamine. Thus coupling to G(olf)alpha appears to mediate D1 signaling in the striatum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924528      PMCID: PMC6772608     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  60 in total

1.  Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Authors:  Francesco Napolitano; Alessandra Bonito-Oliva; Mauro Federici; Manolo Carta; Francesco Errico; Salvatore Magara; Giuseppina Martella; Robert Nisticò; Diego Centonze; Antonio Pisani; Howard H Gu; Nicola B Mercuri; Alessandro Usiello
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

Review 2.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 3.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Localization of D1a dopamine receptors on cell bodies and axonal endings in the substantia nigra pars reticulata of the rat.

Authors:  C Jan; M-P Muriel; A-S Rolland; E C Hirsch; C François
Journal:  J Neural Transm (Vienna)       Date:  2007-06-18       Impact factor: 3.575

5.  Deletion of Go2alpha abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system.

Authors:  Irene Brunk; Christian Blex; Carles Sanchis-Segura; Jan Sternberg; Stephanie Perreau-Lenz; Ainhoa Bilbao; Heide Hörtnagl; Jens Baron; Judyta Juranek; Gregor Laube; Lutz Birnbaumer; Rainer Spanagel; Gudrun Ahnert-Hilger
Journal:  FASEB J       Date:  2008-07-07       Impact factor: 5.191

Review 6.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

7.  Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish.

Authors:  T D Irons; P E Kelly; D L Hunter; R C Macphail; S Padilla
Journal:  Pharmacol Biochem Behav       Date:  2012-12-28       Impact factor: 3.533

8.  Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.

Authors:  D Hervé; C Le Moine; J C Corvol; L Belluscio; C Ledent; A A Fienberg; M Jaber; J M Studler; J A Girault
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

9.  Development of novel biosensors to study receptor-mediated activation of the G-protein α subunits Gs and Golf.

Authors:  Hideaki Yano; Davide Provasi; Ning Sheng Cai; Marta Filizola; Sergi Ferré; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

10.  Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

Authors:  Jean-Christophe Corvol; Marie-Paule Muriel; Emmanuel Valjent; Jean Féger; Naïma Hanoun; Jean-Antoine Girault; Etienne C Hirsch; Denis Hervé
Journal:  J Neurosci       Date:  2004-08-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.